 | • レポートコード：20QY06-00613 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、アシネトバクター感染症用治療のグローバル市場について種類別（スルバクタム、カルバペネム、アミノグリコシド、ポリミキシン、テトラサイクリン、その他）、用途別（ETX2514、ナクバクタムRG6080、アレニシン、VXD-001、低分子抗生物質、AR-401 mAB、LCB01-0371（PO）、GN-4474、抗菌抗体）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・アシネトバクター感染症用治療市場の概要 ・世界の主要地域別アシネトバクター感染症用治療市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のアシネトバクター感染症用治療市場規模2015-2026：種類別（スルバクタム、カルバペネム、アミノグリコシド、ポリミキシン、テトラサイクリン、その他） ・世界のアシネトバクター感染症用治療市場規模2015-2026：用途別（ETX2514、ナクバクタムRG6080、アレニシン、VXD-001、低分子抗生物質、AR-401 mAB、LCB01-0371（PO）、GN-4474、抗菌抗体） ・アシネトバクター感染症用治療の北米市場規模2015-2020 ・アシネトバクター感染症用治療のヨーロッパ市場規模2015-2020 ・アシネトバクター感染症用治療の中国市場規模2015-2020 ・アシネトバクター感染症用治療の日本市場規模2015-2020 ・アシネトバクター感染症用治療の東南アジア市場規模2015-2020 ・アシネトバクター感染症用治療のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Entasis Therapeutics、Roche、Adenium Biotech、Vaxdyn、Hsiri Therapeutics、Aridis Pharmaceuticals、LegoChem Biosciences、Atterx Biotherapeutics、Achaogen、Peptilogics、Sealife PHARMA、Shionogi、Techulon、Tetraphase Pharmaceuticals） ・アシネトバクター感染症用治療の製造コスト分析 ・販売チャネル、流通業者、顧客 ・アシネトバクター感染症用治療の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Acinetobacter Infections Treatment Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Acinetobacter Infections Treatment market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or “species” of Acinetobacter and all can cause human disease, Acinetobacter baumannii accounts for about 80% of reported infections.
Outbreaks of Acinetobacter infections typically occur in intensive care units and healthcare settings housing very ill patients. Acinetobacter infections rarely occur outside of healthcare settings.
Acinetobacter is often resistant to many commonly prescribed antibiotics. Decisions on treatment of infections with Acinetobacter should be made on a case-by-case basis by a healthcare provider. Acinetobacter infection typically occurs in ill patients and can either cause or contribute to death in these patients.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Acinetobacter Infections Treatment market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Acinetobacter Infections Treatment industry.
Based on our recent survey, we have several different scenarios about the Acinetobacter Infections Treatment YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Acinetobacter Infections Treatment will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Acinetobacter Infections Treatment market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Acinetobacter Infections Treatment market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Acinetobacter Infections Treatment market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Acinetobacter Infections Treatment market. The report also includes nautical information, where it shows Acinetobacter Infections Treatment market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Acinetobacter Infections Treatment market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Acinetobacter Infections Treatment market.
In the last several years, global market of Acinetobacter Infections Treatment developed rapidly, with an average growth rate of 2.96%. In 2016, United States Market Size of Acinetobacter Infections Treatment is nearly 22 M USD. For developing product, there are 1 in Phase III, 1 in Phase Ⅱ, 4 in Phase 1 and 8 in Preclinical. The total investment for Acinetobacter Infections Treatmen Drugs developing is around 90 M USD.
Geographical Analysis:
Based on region, the global Acinetobacter Infections Treatment market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Acinetobacter Infections Treatment market are
Entasis Therapeutics
Roche
Adenium Biotech
Vaxdyn
Hsiri Therapeutics
Aridis Pharmaceuticals
LegoChem Biosciences
Atterx Biotherapeutics
Achaogen
Peptilogics
Sealife PHARMA
Shionogi
Techulon
Tetraphase Pharmaceuticals
Segment by Type
Sulbactam
Carbapenems
Aminoglycosides
Polymyxins
Tetracyclines
Others
Segment by Application
ETX2514
Nacubactam RG6080
Arenicin
VXD-001
Small molecule antibiotic
AR-401 mAB
LCB01-0371 (PO)
GN-4474
Antibacterial Antibody
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Acinetobacter Infections Treatment market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Acinetobacter Infections Treatment market.
• The market share of the global Acinetobacter Infections Treatment market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Acinetobacter Infections Treatment market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Acinetobacter Infections Treatment market.
1 Acinetobacter Infections Treatment Market Overview
1.1 Acinetobacter Infections Treatment Product Scope
1.2 Acinetobacter Infections Treatment Segment by Type
1.2.1 Global Acinetobacter Infections Treatment Sales by Type (2020-2026)
1.2.2 Sulbactam
1.2.3 Carbapenems
1.2.4 Aminoglycosides
1.2.5 Polymyxins
1.2.6 Tetracyclines
1.2.7 Others
1.3 Acinetobacter Infections Treatment Segment by Application
1.3.1 Global Acinetobacter Infections Treatment Sales Comparison by Application (2020-2026)
1.3.2 ETX2514
1.3.3 Nacubactam RG6080
1.3.4 Arenicin
1.3.5 VXD-001
1.3.6 Small molecule antibiotic
1.3.7 AR-401 mAB
1.3.8 LCB01-0371 (PO)
1.3.9 GN-4474
1.3.10 Antibacterial Antibody
1.4 Acinetobacter Infections Treatment Market Estimates and Forecasts (2015-2026)
1.4.1 Global Acinetobacter Infections Treatment Sales Growth Rate (2015-2026)
1.4.2 Global Acinetobacter Infections Treatment Revenue and Growth Rate (2015-2026)
1.4.3 Global Acinetobacter Infections Treatment Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Acinetobacter Infections Treatment Industry Impact
1.5.1 How the Covid-19 is Affecting the Acinetobacter Infections Treatment Industry
1.5.1.1 Acinetobacter Infections Treatment Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Acinetobacter Infections Treatment Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Acinetobacter Infections Treatment Players to Combat Covid-19 Impact
2 Acinetobacter Infections Treatment Estimate and Forecast by Region
2.1 Global Acinetobacter Infections Treatment Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Acinetobacter Infections Treatment Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Acinetobacter Infections Treatment Sales Market Share by Region (2015-2020)
2.2.2 Global Acinetobacter Infections Treatment Revenue Market Share by Region (2015-2020)
2.3 Global Acinetobacter Infections Treatment Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Acinetobacter Infections Treatment Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Acinetobacter Infections Treatment Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Acinetobacter Infections Treatment Estimates and Projections (2015-2026)
2.4.2 Europe Acinetobacter Infections Treatment Estimates and Projections (2015-2026)
2.4.3 China Acinetobacter Infections Treatment Estimates and Projections (2015-2026)
2.4.4 Japan Acinetobacter Infections Treatment Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Acinetobacter Infections Treatment Estimates and Projections (2015-2026)
2.4.6 India Acinetobacter Infections Treatment Estimates and Projections (2015-2026)
3 Global Acinetobacter Infections Treatment Competition Landscape by Players
3.1 Global Top Acinetobacter Infections Treatment Players by Sales (2015-2020)
3.2 Global Top Acinetobacter Infections Treatment Players by Revenue (2015-2020)
3.3 Global Acinetobacter Infections Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acinetobacter Infections Treatment as of 2019)
3.4 Global Acinetobacter Infections Treatment Average Price by Company (2015-2020)
3.5 Manufacturers Acinetobacter Infections Treatment Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Acinetobacter Infections Treatment Players (Opinion Leaders)
4 Global Acinetobacter Infections Treatment Market Size by Type
4.1 Global Acinetobacter Infections Treatment Historic Market Review by Type (2015-2020)
4.1.1 Global Acinetobacter Infections Treatment Sales Market Share by Type (2015-2020)
4.1.2 Global Acinetobacter Infections Treatment Revenue Market Share by Type (2015-2020)
4.1.3 Global Acinetobacter Infections Treatment Price by Type (2014-2020)
4.2 Global Acinetobacter Infections Treatment Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Acinetobacter Infections Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global Acinetobacter Infections Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Global Acinetobacter Infections Treatment Price Forecast by Type (2021-2026)
5 Global Acinetobacter Infections Treatment Market Size by Application
5.1 Global Acinetobacter Infections Treatment Historic Market Review by Application (2015-2020)
5.1.1 Global Acinetobacter Infections Treatment Sales Market Share by Application (2015-2020)
5.1.2 Global Acinetobacter Infections Treatment Revenue Market Share by Application (2015-2020)
5.1.3 Global Acinetobacter Infections Treatment Price by Application (2015-2020)
5.2 Global Acinetobacter Infections Treatment Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Acinetobacter Infections Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global Acinetobacter Infections Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global Acinetobacter Infections Treatment Price Forecast by Application (2021-2026)
3 North America Acinetobacter Infections Treatment Market Facts & Figures
3.2 North America Acinetobacter Infections Treatment Sales Market Share by Company (2015-2020)
3.3 North America Acinetobacter Infections Treatment Sales Market Share by Type (2015-2020)
3.4 North America Acinetobacter Infections Treatment Sales Market Share by Application (2015-2020)
4 Europe Acinetobacter Infections Treatment Market Facts & Figures
4.2 Europe Acinetobacter Infections Treatment Sales Market Share by Company (2015-2020)
4.3 Europe Acinetobacter Infections Treatment Sales Market Share by Type (2015-2020)
4.4 Europe Acinetobacter Infections Treatment Sales Market Share by Application (2015-2020)
5 China Acinetobacter Infections Treatment Market Facts & Figures
5.2 China Acinetobacter Infections Treatment Sales Market Share by Company (2015-2020)
5.3 China Acinetobacter Infections Treatment Sales Market Share by Type (2015-2020)
5.4 China Acinetobacter Infections Treatment Sales Market Share by Application (2015-2020)
6 Japan Acinetobacter Infections Treatment Market Facts & Figures
6.2 Japan Acinetobacter Infections Treatment Sales Market Share by Company (2015-2020)
6.3 Japan Acinetobacter Infections Treatment Sales Market Share by Type (2015-2020)
6.4 Japan Acinetobacter Infections Treatment Sales Market Share by Application (2015-2020)
7 Southeast Asia Acinetobacter Infections Treatment Market Facts & Figures
7.2 Southeast Asia Acinetobacter Infections Treatment Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Acinetobacter Infections Treatment Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Acinetobacter Infections Treatment Sales Market Share by Application (2015-2020)
8 India Acinetobacter Infections Treatment Market Facts & Figures
8.2 India Acinetobacter Infections Treatment Sales Market Share by Company (2015-2020)
8.3 India Acinetobacter Infections Treatment Sales Market Share by Type (2015-2020)
8.4 India Acinetobacter Infections Treatment Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Acinetobacter Infections Treatment Business
12.1 Entasis Therapeutics
12.1.1 Entasis Therapeutics Acinetobacter Infections Treatment Corporation Information
12.1.2 Entasis Therapeutics Acinetobacter Infections Treatment Business Overview and Total Revenue
12.1.3 Entasis Therapeutics Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Entasis Therapeutics Acinetobacter Infections Treatment Products Offered
12.1.5 Entasis Therapeutics Recent Development
12.2 Roche
12.2.1 Roche Acinetobacter Infections Treatment Corporation Information
12.2.2 Roche Acinetobacter Infections Treatment Business Overview and Total Revenue
12.2.3 Roche Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Roche Acinetobacter Infections Treatment Products Offered
12.2.5 Roche Recent Development
12.3 Adenium Biotech
12.3.1 Adenium Biotech Acinetobacter Infections Treatment Corporation Information
12.3.2 Adenium Biotech Acinetobacter Infections Treatment Business Overview and Total Revenue
12.3.3 Adenium Biotech Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Adenium Biotech Acinetobacter Infections Treatment Products Offered
12.3.5 Adenium Biotech Recent Development
12.4 Vaxdyn
12.4.1 Vaxdyn Acinetobacter Infections Treatment Corporation Information
12.4.2 Vaxdyn Acinetobacter Infections Treatment Business Overview and Total Revenue
12.4.3 Vaxdyn Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Vaxdyn Acinetobacter Infections Treatment Products Offered
12.4.5 Vaxdyn Recent Development
12.5 Hsiri Therapeutics
12.5.1 Hsiri Therapeutics Acinetobacter Infections Treatment Corporation Information
12.5.2 Hsiri Therapeutics Acinetobacter Infections Treatment Business Overview and Total Revenue
12.5.3 Hsiri Therapeutics Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Hsiri Therapeutics Acinetobacter Infections Treatment Products Offered
12.5.5 Hsiri Therapeutics Recent Development
12.6 Aridis Pharmaceuticals
12.6.1 Aridis Pharmaceuticals Acinetobacter Infections Treatment Corporation Information
12.6.2 Aridis Pharmaceuticals Acinetobacter Infections Treatment Business Overview and Total Revenue
12.6.3 Aridis Pharmaceuticals Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Aridis Pharmaceuticals Acinetobacter Infections Treatment Products Offered
12.6.5 Aridis Pharmaceuticals Recent Development
12.7 LegoChem Biosciences
12.7.1 LegoChem Biosciences Acinetobacter Infections Treatment Corporation Information
12.7.2 LegoChem Biosciences Acinetobacter Infections Treatment Business Overview and Total Revenue
12.7.3 LegoChem Biosciences Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2015-2020)
12.7.4 LegoChem Biosciences Acinetobacter Infections Treatment Products Offered
12.7.5 LegoChem Biosciences Recent Development
12.8 Atterx Biotherapeutics
12.8.1 Atterx Biotherapeutics Acinetobacter Infections Treatment Corporation Information
12.8.2 Atterx Biotherapeutics Acinetobacter Infections Treatment Business Overview and Total Revenue
12.8.3 Atterx Biotherapeutics Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Atterx Biotherapeutics Acinetobacter Infections Treatment Products Offered
12.8.5 Atterx Biotherapeutics Recent Development
12.9 Achaogen
12.9.1 Achaogen Acinetobacter Infections Treatment Corporation Information
12.9.2 Achaogen Acinetobacter Infections Treatment Business Overview and Total Revenue
12.9.3 Achaogen Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Achaogen Acinetobacter Infections Treatment Products Offered
12.9.5 Achaogen Recent Development
12.10 Peptilogics
12.10.1 Peptilogics Acinetobacter Infections Treatment Corporation Information
12.10.2 Peptilogics Acinetobacter Infections Treatment Business Overview and Total Revenue
12.10.3 Peptilogics Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Peptilogics Acinetobacter Infections Treatment Products Offered
12.10.5 Peptilogics Recent Development
12.11 Sealife PHARMA
12.11.1 Sealife PHARMA Acinetobacter Infections Treatment Corporation Information
12.11.2 Sealife PHARMA Acinetobacter Infections Treatment Business Overview and Total Revenue
12.11.3 Sealife PHARMA Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Sealife PHARMA Acinetobacter Infections Treatment Products Offered
12.11.5 Sealife PHARMA Recent Development
12.12 Shionogi
12.12.1 Shionogi Acinetobacter Infections Treatment Corporation Information
12.12.2 Shionogi Acinetobacter Infections Treatment Business Overview and Total Revenue
12.12.3 Shionogi Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Shionogi Acinetobacter Infections Treatment Products Offered
12.12.5 Shionogi Recent Development
12.13 Techulon
12.13.1 Techulon Acinetobacter Infections Treatment Corporation Information
12.13.2 Techulon Acinetobacter Infections Treatment Business Overview and Total Revenue
12.13.3 Techulon Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Techulon Acinetobacter Infections Treatment Products Offered
12.13.5 Techulon Recent Development
12.14 Tetraphase Pharmaceuticals
12.14.1 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Corporation Information
12.14.2 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Business Overview and Total Revenue
12.14.3 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Products Offered
12.14.5 Tetraphase Pharmaceuticals Recent Development
13 Acinetobacter Infections Treatment Manufacturing Cost Analysis
13.1 Acinetobacter Infections Treatment Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Acinetobacter Infections Treatment
13.4 Acinetobacter Infections Treatment Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Acinetobacter Infections Treatment Distributors List
14.3 Acinetobacter Infections Treatment Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Acinetobacter Infections Treatment Sales (Cases) Growth Rate by Type (2020-2026)
Table 2. Global Acinetobacter Infections Treatment Sales (Cases) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Acinetobacter Infections Treatment Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Acinetobacter Infections Treatment Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Acinetobacter Infections Treatment Players to Combat Covid-19 Impact
Table 8. Global Market Acinetobacter Infections Treatment Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Acinetobacter Infections Treatment Sales (Cases) by Region (2015-2020)
Table 10. Global Acinetobacter Infections Treatment Sales Market Share by Region (2015-2020)
Table 11. Global Acinetobacter Infections Treatment Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Acinetobacter Infections Treatment Revenue Share by Region (2015-2020)
Table 13. Global Acinetobacter Infections Treatment Sales (Cases) Forecast by Region (2021-2026)
Table 14. Global Acinetobacter Infections Treatment Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Acinetobacter Infections Treatment Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Acinetobacter Infections Treatment Revenue Share Forecast by Region (2021-2026)
Table 17. Global Acinetobacter Infections Treatment (Cases) of Key Companies (2015-2020)
Table 18. Global Acinetobacter Infections Treatment Sales Share by Company (2015-2020)
Table 19. Global Acinetobacter Infections Treatment Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Acinetobacter Infections Treatment Revenue Share by Company (2015-2020)
Table 21. Global Acinetobacter Infections Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acinetobacter Infections Treatment as of 2019)
Table 22. Global Acinetobacter Infections Treatment Average Price (USD/Case) of Key Company (2015-2020)
Table 23. Manufacturers Acinetobacter Infections Treatment Manufacturing Sites and Area Served
Table 24. Manufacturers Acinetobacter Infections Treatment Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Acinetobacter Infections Treatment Players
Table 27. Global Acinetobacter Infections Treatment Sales (Cases) by Type (2015-2020)
Table 28. Global Acinetobacter Infections Treatment Sales Share by Type (2015-2020)
Table 29. Global Acinetobacter Infections Treatment Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Acinetobacter Infections Treatment Price (Cases) by Type (2015-2020)
Table 31. Global Acinetobacter Infections Treatment Sales Share by Type (2021-2026)
Table 32. Global Acinetobacter Infections Treatment Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Acinetobacter Infections Treatment Revenue Share by Type (2021-2026)
Table 34. Global Acinetobacter Infections Treatment Price (Cases) by Type (2021-2026)
Table 35. Global Acinetobacter Infections Treatment Sales (Cases) by Application (2015-2020)
Table 36. Global Acinetobacter Infections Treatment Sales Share by Application (2015-2020)
Table 37. Global Acinetobacter Infections Treatment Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Acinetobacter Infections Treatment Price (Cases) by Application (2015-2020)
Table 39. Global Acinetobacter Infections Treatment Sales (Cases) by Application (2021-2026)
Table 40. Global Acinetobacter Infections Treatment Sales Share by Application (2021-2026)
Table 41. Global Acinetobacter Infections Treatment Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Acinetobacter Infections Treatment Revenue Share by Application (2021-2026)
Table 43. Global Acinetobacter Infections Treatment Price (Cases) by Application (2021-2026)
Table 44. United States Acinetobacter Infections Treatment Sales (Cases) by Company (2015-2020)
Table 45. United States Acinetobacter Infections Treatment Sales Market Share by Company (2015-2020)
Table 46. United States Acinetobacter Infections Treatment Sales (Cases) by Type (2015-2020)
Table 47. United States Acinetobacter Infections Treatment Sales Market Share by Type (2015-2020)
Table 48. United States Acinetobacter Infections Treatment Sales (Cases) by Application (2015-2020)
Table 49. United States Acinetobacter Infections Treatment Sales Market Share by Application (2015-2020)
Table 50. Europe Acinetobacter Infections Treatment Sales (Cases) by Company (2015-2020)
Table 51. Europe Acinetobacter Infections Treatment Sales Market Share by Company (2015-2020)
Table 52. Europe Acinetobacter Infections Treatment Sales (Cases) by Type (2015-2020)
Table 53. Europe Acinetobacter Infections Treatment Sales Market Share by Type (2015-2020)
Table 54. Europe Acinetobacter Infections Treatment Sales (Cases) by Application (2015-2020)
Table 55. Europe Acinetobacter Infections Treatment Sales Market Share by Type (2015-2020)
Table 56. China Acinetobacter Infections Treatment Sales (Cases) by Company (2015-2020)
Table 57. China Acinetobacter Infections Treatment Sales Market Share by Company (2015-2020)
Table 58. China Acinetobacter Infections Treatment Sales (Cases) by Type (2015-2020)
Table 59. China Acinetobacter Infections Treatment Sales Market Share by Type (2015-2020)
Table 60. China Acinetobacter Infections Treatment Sales (Cases) by Application (2015-2020)
Table 61. China Acinetobacter Infections Treatment Sales Market Share by Application (2015-2020)
Table 62. Japan Acinetobacter Infections Treatment Sales (Cases) by Company (2015-2020)
Table 63. Japan Acinetobacter Infections Treatment Sales Market Share by Company (2015-2020)
Table 64. Japan Acinetobacter Infections Treatment Sales (Cases) by Type (2015-2020)
Table 65. Japan Acinetobacter Infections Treatment Sales Market Share by Type (2015-2020)
Table 66. Japan Acinetobacter Infections Treatment Sales (Cases) by Application (2015-2020)
Table 67. Japan Acinetobacter Infections Treatment Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Acinetobacter Infections Treatment Sales (Cases) by Company (2015-2020)
Table 69. Southeast Asia Acinetobacter Infections Treatment Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Acinetobacter Infections Treatment Sales (Cases) by Type (2015-2020)
Table 71. Southeast Asia Acinetobacter Infections Treatment Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Acinetobacter Infections Treatment Sales (Cases) by Type (2015-2020)
Table 73. Southeast Asia Acinetobacter Infections Treatment Sales Market Share by Application (2015-2020)
Table 74. India Acinetobacter Infections Treatment Sales (Cases) by Company (2015-2020)
Table 75. India Acinetobacter Infections Treatment Sales Market Share by Company (2015-2020)
Table 76. India Acinetobacter Infections Treatment Sales (Cases) by Type (2015-2020)
Table 77. India Acinetobacter Infections Treatment Sales Market Share by Type (2015-2020)
Table 78. India Acinetobacter Infections Treatment Sales (Cases) by Application (2015-2020)
Table 79. India Acinetobacter Infections Treatment Sales Market Share by Application (2015-2020)
Table 80. Entasis Therapeutics Corporation Information
Table 81. Entasis Therapeutics Description and Business Overview
Table 82. Entasis Therapeutics Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2015-2020)
Table 83. Entasis Therapeutics Acinetobacter Infections Treatment Product
Table 84. Entasis Therapeutics Recent Development
Table 85. Roche Corporation Information
Table 86. Roche Description and Business Overview
Table 87. Roche Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2015-2020)
Table 88. Roche Acinetobacter Infections Treatment Product
Table 89. Roche Recent Development
Table 90. Adenium Biotech Corporation Information
Table 91. Adenium Biotech Description and Business Overview
Table 92. Adenium Biotech Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2015-2020)
Table 93. Adenium Biotech Acinetobacter Infections Treatment Product
Table 94. Adenium Biotech Recent Development
Table 95. Vaxdyn Corporation Information
Table 96. Vaxdyn Description and Business Overview
Table 97. Vaxdyn Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2015-2020)
Table 98. Vaxdyn Acinetobacter Infections Treatment Product
Table 99. Vaxdyn Recent Development
Table 100. Hsiri Therapeutics Corporation Information
Table 101. Hsiri Therapeutics Description and Business Overview
Table 102. Hsiri Therapeutics Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2015-2020)
Table 103. Hsiri Therapeutics Acinetobacter Infections Treatment Product
Table 104. Hsiri Therapeutics Recent Development
Table 105. Aridis Pharmaceuticals Corporation Information
Table 106. Aridis Pharmaceuticals Description and Business Overview
Table 107. Aridis Pharmaceuticals Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2015-2020)
Table 108. Aridis Pharmaceuticals Acinetobacter Infections Treatment Product
Table 109. Aridis Pharmaceuticals Recent Development
Table 110. LegoChem Biosciences Corporation Information
Table 111. LegoChem Biosciences Description and Business Overview
Table 112. LegoChem Biosciences Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2015-2020)
Table 113. LegoChem Biosciences Acinetobacter Infections Treatment Product
Table 114. LegoChem Biosciences Recent Development
Table 115. Atterx Biotherapeutics Corporation Information
Table 116. Atterx Biotherapeutics Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2015-2020)
Table 117. Atterx Biotherapeutics Description and Business Overview
Table 118. Atterx Biotherapeutics Acinetobacter Infections Treatment Product
Table 119. Atterx Biotherapeutics Recent Development
Table 120. Achaogen Corporation Information
Table 121. Achaogen Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2015-2020)
Table 122. Achaogen Description and Business Overview
Table 123. Achaogen Acinetobacter Infections Treatment Product
Table 124. Achaogen Recent Development
Table 125. Peptilogics Corporation Information
Table 126. Peptilogics Description and Business Overview
Table 127. Peptilogics Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2015-2020)
Table 128. Peptilogics Acinetobacter Infections Treatment Product
Table 129. Peptilogics Recent Development
Table 130. Sealife PHARMA Corporation Information
Table 131. Sealife PHARMA Description and Business Overview
Table 132. Sealife PHARMA Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2015-2020)
Table 133. Sealife PHARMA Acinetobacter Infections Treatment Product
Table 134. Sealife PHARMA Recent Development
Table 135. Shionogi Corporation Information
Table 136. Shionogi Description and Business Overview
Table 137. Shionogi Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2015-2020)
Table 138. Shionogi Acinetobacter Infections Treatment Product
Table 139. Shionogi Recent Development
Table 140. Techulon Corporation Information
Table 141. Techulon Description and Business Overview
Table 142. Techulon Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2015-2020)
Table 143. Techulon Acinetobacter Infections Treatment Product
Table 144. Techulon Recent Development
Table . Tetraphase Pharmaceuticals Corporation Information
Table . Tetraphase Pharmaceuticals Description and Business Overview
Table . Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2015-2020)
Table . Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Product
Table . Tetraphase Pharmaceuticals Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Acinetobacter Infections Treatment Distributors List
Table 153. Acinetobacter Infections Treatment Customers List
Table 154. Market Key Trends
Table 155. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 156. Key Challenges
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Acinetobacter Infections Treatment Product Picture
Figure 2. Global Acinetobacter Infections Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Acinetobacter Infections Treatment Market Share by Application in 2020 & 2026
Figure 6. ETX2514 Examples
Figure 7. Nacubactam RG6080 Examples
Figure 8. Arenicin Examples
Figure 9. VXD-001 Examples
Figure 10. Small molecule antibiotic Examples
Figure 11. AR-401 mAB Examples
Figure 12. LCB01-0371 (PO) Examples
Figure 13. GN-4474 Examples
Figure 14. Antibacterial Antibody Examples
Figure 15. Global Acinetobacter Infections Treatment Sales (Cases) Growth Rate (2015-2026)
Figure 16. Global Acinetobacter Infections Treatment Revenue (US$ Million) Growth Rate (2015-2026)
Figure 17. Global Acinetobacter Infections Treatment Price Trends Growth Rate (2015-2026) (USD/Case)
Figure 18. Global Acinetobacter Infections Treatment Revenue Market Share by Region: 2015 VS 2020
Figure 19. Global Acinetobacter Infections Treatment Revenue Market Share by Region: 2021 VS 2026
Figure 20. United States Acinetobacter Infections Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. United States Acinetobacter Infections Treatment Sales (Cases) Growth Rate (2015-2026)
Figure 22. Europe Acinetobacter Infections Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Europe Acinetobacter Infections Treatment Sales (Million USD) Growth Rate (2015-2026)
Figure 24. China Acinetobacter Infections Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. China Acinetobacter Infections Treatment Sales (Million USD) and Growth Rate (2015-2026)
Figure 26. Japan Acinetobacter Infections Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. Japan Acinetobacter Infections Treatment Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Southeast Asia Acinetobacter Infections Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 29. Southeast Asia Acinetobacter Infections Treatment Sales (Million USD) Growth Rate (2015-2026)
Figure 30. India Acinetobacter Infections Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 31. India Acinetobacter Infections Treatment Sales (Million USD) Growth Rate (2015-2026)
Figure 32. Global 5 Largest Acinetobacter Infections Treatment Players Market Share by Revenue in Acinetobacter Infections Treatment 2015 & 2019
Figure 33. Acinetobacter Infections Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 34. Global Acinetobacter Infections Treatment Revenue Share by Type (2015-2020)
Figure 35. Global Acinetobacter Infections Treatment Revenue Growth Rate by Type in 2015 & 2019
Figure 36. Global Acinetobacter Infections Treatment Revenue Share by Application (2015-2020)
Figure 37. Global Acinetobacter Infections Treatment Revenue Growth Rate by Application in 2015 & 2019
Figure 38. United States Acinetobacter Infections Treatment Sales Market Share by Type in 2019
Figure 39. United States Acinetobacter Infections Treatment Sales Market Share by Type in 2019
Figure 40. Europe Acinetobacter Infections Treatment Sales Market Share by Company in 2019
Figure 41. Europe Acinetobacter Infections Treatment Sales Market Share by Type in 2019
Figure 42. Europe Acinetobacter Infections Treatment Sales Market Share by Application in 2019
Figure 43. China Acinetobacter Infections Treatment Sales Market Share by Company in 2019
Figure 44. China Acinetobacter Infections Treatment Sales Market Share by Type in 2019
Figure 45. China Acinetobacter Infections Treatment Sales Market Share by Application in 2019
Figure 46. Japan Acinetobacter Infections Treatment Sales Market Share by Company in 2019
Figure 47. Japan Acinetobacter Infections Treatment Sales Market Share by Type in 2019
Figure 48. Japan Acinetobacter Infections Treatment Sales Market Share by Application in 2019
Figure 49. Southeast Asia Acinetobacter Infections Treatment Sales Market Share by Company in 2019
Figure 50. Southeast Asia Acinetobacter Infections Treatment Sales Market Share by Type in 2019
Figure 51. Southeast Asia Acinetobacter Infections Treatment Sales Market Share by Application in 2019
Figure 52. India Acinetobacter Infections Treatment Sales Market Share by Company in 2019
Figure 53. India Acinetobacter Infections Treatment Sales Market Share by Type in 2019
Figure 54. India Acinetobacter Infections Treatment Sales Market Share by Application in 2019
Figure 55. Entasis Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Adenium Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Vaxdyn Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Hsiri Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Aridis Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. LegoChem Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Atterx Biotherapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Achaogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Peptilogics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Sealife PHARMA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Shionogi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Techulon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Tetraphase Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. Key Raw Materials Price Trend
Figure 70. Manufacturing Cost Structure of Acinetobacter Infections Treatment
Figure 71. Manufacturing Process Analysis of Acinetobacter Infections Treatment
Figure 72. Acinetobacter Infections Treatment Industrial Chain Analysis
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles
Figure 75. Porter's Five Forces Analysis
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
圧縮空気処理装置の世界市場レポート2020 Compressed Air Treatment Equipment is engineered to work specifically with rotary screw and reciprocating compressors. Compressed air applications range from general purpose shop air to breathing air-with a wide range of applications in between. Market Analysis and Insights: Global Compressed Air Tr…- エントリーポイント用水処理システムの世界市場レポート2020 Market Analysis and Insights: Global Point of Entry Water Treatment Systems Market The global Point of Entry Water Treatment Systems market was valued at US$ 6421.2 million in 2019 and will reach US$ 7555.7 million by the end of 2026, growing at a CAGR of 2.3% during 2020-2026. Global Point of Entry…
- ラボ用高純度水処理の世界市場レポート2020 QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients. Report Overview: The global Laboratory High-Purity Water T…
- クラッベ病治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Krabbe Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Krabbe Disease Treat…
- 院内感染管理の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Hospital Acquired Infection Control market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.5% in the forecast period of 2020 to 2025 and will expected to reach USD 1179.1 million by 2025, from USD 1068.4 million in 2019. The …